通过脚手架跳跃和碎片生长来从阿莫迪亚奎因中开发Nurr1激动剂
Minh Sai1, Emily C Hank1, Hin-Man Tai2
1Ludwig-Maximilians-Universität München, Department of Pharmacy, 81377, Munich, Germany.
研究人员开发了新的Nurr1激动剂,以向像帕金森氏症这样的神经退行性疾病. 这些强大的化学工具对神经系统疾病的治疗开发和生物研究有前途.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 与核受体相关的1 (Nurr1) 是一种神经保护性转录因子,对帕金森病,阿尔茨海默病和多发性硬化症具有治疗潜力.
- 对于Nurr1目标验证的高质量的化学工具很少,这阻碍了药物开发.
研究的目的:
- 设计和合成具有高强度和结合亲和力的新型Nurr1激动剂.
- 开发一种用于Nurr1调制的新化学型.
- 验证这些激动剂作为治疗线索和研究工具的潜力.
主要方法:
- 利用基于弱Nurr1调节器阿莫迪亚奎因 (AQ) 的架构跳跃和碎片生长策略.
- 进行了系统的结构优化,以增强激剂特性.
- 进行了全面的体外分析,并对具有与帕金森病相关的LRRK2突变的人类中脑器官进行了测试.
主要成果:
- 开发了具有纳米分子功效和结合亲和力的新型Nurr1激动剂.
- 证明了高效的蜂目标参与,并满足了高探测标准.
- 在帕金森病模型中展示了氨酸氧酶表达的救援.
结论:
- 一种新的Nurr1激动剂化学型成功设计和优化.
- 这些新型激动剂作为生物研究的有价值的化学工具和神经退行性疾病的潜在治疗线索.
更多相关视频
09:04A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Preparation of 1° Amines: Gabriel Synthesis
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Drug Discovery: Overview
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Mechanism
